{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:34:05Z","timestamp":1779914045599,"version":"3.53.1"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:00:00Z","timestamp":1700524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Mycoplasma pneumoniae<\/jats:italic> pneumonia (MPP) is common among children, but the impact of atopy on MPP severity in children is unknown. This study investigated whether atopic vs. nonatopic children had greater MPP severity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective analysis was conducted on 539 (ages 3\u201314 years) patients who were hospitalized in the First Affiliated Hospital of Anhui Medical University for MPP between January 2018 and December 2021, 195 were atopic and 344 were nonatopic. Of them, 204 had refractory MPP, and 335 had general MPP. And of atopic children, 94 had refractory MPP, and 101 had general MPP. Data on demographic and clinical characteristics, laboratory findings, clinical treatments were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Significantly more boys with MPP were atopic than nonatopic (<jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.05). More atopic (than nonatopic) children presented with prolonged fever and hospitalization, severe extra-pulmonary complications, asthma attaking, steroid and oxygen treatment, and increased IgE levels (all <jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.05). In atopic (vs. nonatopic) children with MPP, the incidence of sputum plugs under the fiberoptic bronchoscopy and lobar pneumonia was significantly increased and required bronchoscopy-assisted and steroid therapy. Compared with nonatopic children, more atopic children developed refractory MPP (<jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.05). Prolonged fever and hospitalization, severe extra-pulmonary complications, lymphocyte count, procalcitonin and lactate dehydrogenase levels, and percentages of atopy were all significantly higher (<jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.05) among children with refractory MPP vs. general MPP. Moreover, Prolonged fever and hospitalization, lymphocyte count, procalcitonin and lactate dehydrogenase levels, and the treantment of steroid were all significantly higher (<jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.05) among atopic children with refractory MPP vs. general MPP. Spearman correlation analysis showed strong associations between atopy and male sex, length of hospital stay, fever duration, IgE level, wheezing, lobar pneumonia, refractory MPP, and treatment with oxygen, hormones or bronchoscopy (<jats:italic>P\u2009<\/jats:italic>&amp;lt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Atopy may be a risk factor for and was positively correlated with the severity of MPP in children.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2023.1281479","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T15:13:37Z","timestamp":1700752417000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Association of atopy with disease severity in children with Mycoplasma pneumoniae pneumonia"],"prefix":"10.3389","volume":"11","author":[{"given":"ChenRong","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SongTao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShaoHu","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BeiBei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PingPing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenHong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShengGang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2008.06.012","article-title":"Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children","volume":"57","author":"Tamura","year":"2008","journal-title":"J Infect"},{"key":"B2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijid.2014.07.020","article-title":"Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children","volume":"29","author":"Wang","year":"2014","journal-title":"Int J Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/ppul.22752","article-title":"Effects of prednisolone on refractory Mycoplasma pneumoniae pneumonia in children","volume":"49","author":"Luo","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ppul.20374","article-title":"Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children","volume":"41","author":"Lee","year":"2006","journal-title":"Pediatr Pulmonol"},{"key":"B5","article-title":"Atopy","volume-title":"StatPearls [Internet]","author":"Justiz Vaillant","year":"2023"},{"key":"B6","doi-asserted-by":"publisher","first-page":"k2698","DOI":"10.1136\/bmj.k2698","article-title":"Recurrent lower respiratory tract infections in children","volume":"362","author":"de Benedictis","year":"2018","journal-title":"Br Med J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.19335\/j.cnki.2096-1219.2021.26.019","article-title":"Logistic regression analysis on the predisposing factors, prevention and treatment of recurrent respiratory tract infection in children","volume":"7","author":"Huang","year":"2021","journal-title":"Wisdom Health"},{"key":"B8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/crj.12439","article-title":"Atopy: a risk factor of refractory Mycoplasma pneumoniae pneumonia?","volume":"11","author":"Bao","year":"2017","journal-title":"Clin Respir J"},{"key":"B9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1165\/rcmb.2011-0135OC","article-title":"Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation","volume":"46","author":"Medina","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1128\/IAI.71.3.1520-1526.2003","article-title":"Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice","volume":"71","author":"Chu","year":"2003","journal-title":"Infect Immun"},{"key":"B11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/cea.12050","article-title":"Specific patterns of allergic sensitization in early childhood and asthma & rhinitis risk","volume":"43","author":"Stoltz","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00281-020-00785-1","article-title":"Asthma epidemiology and risk factors","volume":"42","author":"Stern","year":"2020","journal-title":"Semin Immunopathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1128\/CDLI.11.5.862-867.2004","article-title":"Analysis of eight commercial enzyme immunoassay tests for detection of antibodies to Mycoplasma pneumoniae in human serum","volume":"11","author":"Talkington","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"B14","first-page":"745","article-title":"Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I)","volume":"51","year":"2013","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B15","doi-asserted-by":"publisher","first-page":"87391","DOI":"10.3389\/fcimb.2021.687391","article-title":"The level of D-dimer is positively correlated with the severity of Mycoplasma pneumoniae pneumonia in children","volume":"11","author":"Zheng","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"B16","first-page":"4658","article-title":"Analysis on clinical characteristics of Mycoplasma pneumoniae pneumonia in children with allergic constitution","volume":"33","author":"Xiuling","year":"2018","journal-title":"Matern Child Health Care China"},{"key":"B17","doi-asserted-by":"publisher","first-page":"20081","DOI":"10.2807\/ese.17.06.20081-en","article-title":"Increased detection of Mycoplasma pneumoniae infection in children in England and Wales, October 2011 to January 2012","volume":"17","author":"Chalker","year":"2012","journal-title":"Euro Surveill"},{"key":"B18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12519-011-0318-0","article-title":"Epidemiological characteristics and meteorological factors of childhood Mycoplasma pneumoniae pneumonia in Hangzhou","volume":"7","author":"Xu","year":"2011","journal-title":"World J Pediatr"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/infdis\/jir557","article-title":"Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model","volume":"204","author":"Kannan","year":"2011","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10020-019-0105-2","article-title":"High co-expression of TNF-\u03b1 and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia","volume":"25","author":"Li","year":"2019","journal-title":"Mol Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"986527","DOI":"10.1155\/2014\/986527","article-title":"Mycoplasma pneumoniae infection in children is a risk factor for developing allergic diseases","volume":"2014","author":"Ye","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"B22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.anai.2018.03.014","article-title":"Mycoplasma pneumoniae induces allergy by producing P1-specific immunoglobulin E","volume":"121","author":"Ye","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1067\/mai.2001.113563","article-title":"A link between chronic asthma and chronic infection","volume":"107","author":"Martin","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.annepidem.2009.11.007","article-title":"Subsequent autoimmune or related disease in asthma patients: clustering of diseases or medical care?","volume":"20","author":"Hemminki","year":"2010","journal-title":"Ann Epidemiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nri2273","article-title":"IgE in allergy and asthma today","volume":"8","author":"Gould","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B26","first-page":"729","volume":"51","year":"2013","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B27","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1157\/13112987","article-title":"Risk factors of developing asthma in children with recurrent wheezing in the first three years of life","volume":"35","author":"Alvarez","year":"2007","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jiac.2014.10.008","article-title":"Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults","volume":"21","author":"Miyashita","year":"2015","journal-title":"J Infect Chemother"},{"key":"B29","doi-asserted-by":"publisher","first-page":"e22887","DOI":"10.1002\/jcla.22887","article-title":"Impact of atopy on the severity and extrapulmonary manifestations of childhood Mycoplasma pneumoniae pneumonia","volume":"33","author":"Wang","year":"2019","journal-title":"J Clin Lab Anal"},{"key":"B30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.iac.2015.05.004","article-title":"Eosinophilia associated with disorders of immune deficiency or immune dysregulation","volume":"35","author":"Williams","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.2500\/aap.2014.35.3734","article-title":"Selective IgE deficiency, immune dysregulation, and autoimmunity","volume":"35","author":"Magen","year":"2014","journal-title":"Allergy Asthma Proc"},{"key":"B32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/cea.12296","article-title":"Airway epithelial barrier function regulates the pathogenesis of allergic asthma","volume":"44","author":"Heijink","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"B33","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.alit.2017.08.011","article-title":"Role of airway epithelial barrier dysfunction in pathogenesis of asthma","volume":"67","author":"Gon","year":"2018","journal-title":"Allergol Int"},{"key":"B34","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1097\/BOR.0000000000000494","article-title":"Extra-pulmonary diseases related to Mycoplasma pneumoniae in children: recent insights into the pathogenesis","volume":"30","author":"Poddighe","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1135228","DOI":"10.3389\/fcimb.2023.1135228","article-title":"Clinical features and \u201cearly\u201d corticosteroid treatment outcome of pediatric Mycoplasma pneumoniae pneumonia","volume":"13","author":"Liu","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1207512","DOI":"10.1155\/2022\/1207512","article-title":"Efficacy of azithromycin plus glucocorticoid adjuvant therapy on serum inflammatory factor levels and incidence of adverse reactions in children with Mycoplasma pneumonia","volume":"2022","author":"Cao","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1186\/s12879-023-08619-9","article-title":"Optimization strategy for the early timing of bronchoalveolar lavage treatment for children with severe Mycoplasma pneumoniae pneumonia","volume":"23","author":"Wu","year":"2023","journal-title":"BMC Infect Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.7499\/j.issn.1008-8830.2018.04.009","article-title":"Efficacy of early treatment via fiber bronchoscope in children with Mycoplasma pneumoniae pneumonia complicated by airway mucus obstruction","volume":"20","author":"Cao","year":"2018","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5427","DOI":"10.19829\/j.zgfybj.issn.1001-4411.2021.23.020","article-title":"Correlation between atopic constitution and post-infectious cough in children","volume":"36","author":"Rong","year":"2021","journal-title":"China J Matern Child Health"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1281479\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T15:13:46Z","timestamp":1700752426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2023.1281479\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,21]]},"references-count":39,"alternative-id":["10.3389\/fped.2023.1281479"],"URL":"https:\/\/doi.org\/10.3389\/fped.2023.1281479","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,21]]},"article-number":"1281479"}}